Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart study

Circulation

Volumn 108, Issue 5, 2003, Pages 519-523

  Hopkins, Paul N ^a,g   Heiss, Gerardo ^b   Ellison, R Curtis ^c   Province, Michael A ^d   Pankow, James S ^e   Eckfeldt, John H ^f   Hunt, Steven C ^a  

^a UNIVERSITY OF UTAH   (United States)

^b IL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g Cardiovascular Genetics   (United States)

Author keywords

Coronary disease; Epidemiology; Genetics; Lipoproteins

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL GENETICS; CLINICAL MEDICINE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILIAL HYPERLIPEMIA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTIMA; MAJOR CLINICAL STUDY; POPULATION; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TUNICA MEDIA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; FAMILY; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTICENTER STUDIES; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; UNITED STATES;

EID: 0042074140     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000081777.17879.85     Document Type: Article

References (29)

1. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism. 1976;25:313-320.
2. Austin MA, McKnight B, Edwards KL, et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation. 2000;101:2777-2782.
3. Goldstein J, Schrott H, Hazzard W. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-1568.
4. Genest JJ, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85:2025-2033.
5. Higgins M, Province M, Heiss G, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol. 1996;143:1219-1228.
6. Coon H, Myers RH, Borecki IB, et al. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus: the NHLBI family heart study. Arterioscler Thromb Vasc Biol. 2000;20:2275-2280.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
8. Lipid Research Clinics Population Studies Data Book, Vol 1: The Prevalence Study. Washington, DC: US Department of Health and Human Services, Public Health Service, NIH Publ No. 80-1527; 1980.
9. Williams RR, Hunt SC, Schumacher MC, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol. 1993;72:171-176.
10. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
11. Goldstein J, Hazzard W, Schrott H. Hyperlipidemia in coronary heart disease, I: Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973;52:1533-1543.
12. Hopkins PN, Wu LL, Schumacher MC, et al. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction. Arterioscler Thromb. 1991;11:1137-1146.
13. Wu LL, Hopkins PN, Xin Y, et al. Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalities. J Hum Genet. 2000;45:154-158.
14. Carmena R, Roy M, Roederer G, et al. Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations. Atherosclerosis. 2000;148:113-124.
15. Kwiterovich PO. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol. 1993;4:133-143.
16. Pajukanta P, Terwilliger JD, Perola M, et al. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet. 1999;64:1453-1463.
17. Purnell JQ, Kahn SE, Schwartz RS, et al. Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2001;21:567-572.
18. Veerkamp MJ, de Graaf J, Bredie SJ, et al. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol. 2002;22:274-282.
19. Lapinleimu J, Nuotio IO, Lapinleimu H, et al. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents: The STRIP project. Atherosclerosis. 2002;160:417-423.
20. Nikkila EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet. 1973;1:954-959.
21. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: R. SC, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill; 2001:2717-2752.
22. Aguilar-Salinas CA, Hugh P, Barrett R, et al. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism: kinetics of apolipoprotein B during placebo and pravastatin therapy. Arterioscler Thromb Vasc Biol. 1997;17:72-82.
23. Kissebah AH, Alfarsi S, Adams PW. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 1981;30:856-868.
24. Sane T, Nikkila EA. Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Arteriosclerosis. 1988;8:217-226.
25. Wilson DE, Emi M, Iverius PH, et al. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest. 1990;86:735-50.
26. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb. 1992;12:1176-1183.
27. Williams KJ, Petrie KA, Brocia RW, et al. Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro: a possible pathophysiologic explanation for familial combined hyperlipidemia. J Clin Invest. 1991;88:1300-1306.
28. Hopkins PN, Hunt SC, Wu LL, et al. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? Curr Opin Lipidol. 1996;7:241-253.
29. Pihlajamaki J, Karjalainen L, Karhapaa P, et al. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hyperlriglyceridemic patients. Arterioscler Thromb Vasc Biol. 2000;20:164-170.